HIV Scientific Papers
Significant improvement in belly image parameters and health-related quality of life in responders vs. non-responders to tesamorelin, a growth hormone-releasing factor (GRF) analogue, in HIV-infected patients with excess abdominal fat.
2011
Turner R, Potvin D, Mamputu J-C, et al.
Poster PE9.3/2 presented at: 13th European AIDS Conference; October 12-15, 2011; Belgrade, Serbia.
Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.
2011
J Clin Endocrinol Metab.
Stanley TL, Chen CY, Branch KL, et al.
96(1):150-158. Epub 2010 Oct 13.
Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factor.
2011
Growth Horm IGF Res.
Makimura H, Stanley TL, Chen CY, et al.
21(3):155-159.
Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.
2011
AIDS.
Stanley TL, Falutz J, Mamputu J-C, et al.
25(10):1281-1288.
Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection.
2010
J Antimicrob Chemother.
Bruno CJ, Jacobson JM.
65(9):1839-1841.